| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,133 |
2,485 |
$215K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
604 |
544 |
$61K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
810 |
632 |
$39K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
348 |
331 |
$30K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,801 |
1,492 |
$20K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
508 |
395 |
$14K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,195 |
945 |
$11K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
76 |
71 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
731 |
604 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
938 |
748 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
704 |
583 |
$332.51 |
| 81003 |
|
30 |
28 |
$43.92 |